BioCryst Pharmaceuticals | Umlaufvermögen

Aktienkurs
6.55
Täglich Wechseln
0.25 3.97%
Monatlich
-7.62%
Jährlich
-27.14%
Q1 Prognose
4.65




Umlaufvermögen Veränderung Datum
Alnylam Pharmaceuticals USD 3.95B 309.11M 2025-09
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
Chugai Pharma JPY 1.74T 223.03B 2025-12
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
DBV Technologies USD 88.88M 32.36M 2025-09
Enanta Pharmaceuticals USD 204.34M 18.37M 2025-09
Gilead Sciences USD 18.84B 4.12B 2025-09
GlaxoSmithKline GBP 17.51B 332M 2025-12
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Neurocrine Biosciences USD 2.16B 409.5M 2025-09
Novavax USD 974.59M 55.08M 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 10.57B 141.7M 2025-09


BioCryst Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.